The Mission of the International Institute for Restorative Reproductive Medicine is to advance excellence in Restorative Reproductive Medicine (RRM) by supporting practice and research through mentorship, education and collaboration
The International Institute for Restorative Reproductive Medicine is the leading voice in uniting providers who share a common belief that patients deserve scientifically-based and well researched reproductive health care services that cooperate with and restore reproductive function.
To address reproductive health problems, Restorative Reproductive Medicine (RRM) clinicians focus investigations and treatments on correcting abnormalities, rather than suppressing, destroying or bypassing normal function. This approach inherently centers on the patient, who becomes an integral part of the care team as they observe and record how their bodies respond. The result is an empowered patient who is able to communicate and understand their condition and any necessary treatments.
Formal discussion of forming a research institute first took place in November 2000, involving physicians from Canada, Ireland and the UK. Subsequent organizational meetings involved additional representatives from Australia and the United States, and resulted in the formal creation of the International Institute for Restorative Reproductive Medicine (IIRRM).
The founding of the IIRRM evolved from discussions amongst doctors training in 1999 regarding the need to further generate, promote and publish ongoing research into NPT and other scientific work serving the purposes of restorative reproductive medicine. The vision was to unite all providers of RRM services, regardless of which method they used to assist their patients. The need for a united voice was clear if we were to establish lasting change in reproductive medicine and the world around us.
The first research project involved an in-depth review of the outcomes of NPT treatment for infertility in an Irish practice, and the establishment of an international prospective surveillance study, the iNEST study. Organizational development continues with many physicians participating in the annual general meetings of the Institute held in July. The Board meets 3 or 4 times a year and biweekly by teleconference.